Nosocomial infections with enterococci are an increasing problem in modern medical practice due to the development of resistance to a wide range of antibiotics, including the glycopeptides vancomycin and teicoplanin. An increasing number of vancomycin-resistant enterococci (VRE) have been cultured from clinical specimens -- especially from patients undergoing immunosuppressive therapy -- and ba...

methicillin-resistant Staphylococcus aureus (MRSA) in hospitals have become a serious clinical problem. A glycopeptide antibiotic, vancomycin, has been used for the treatment of infections due to MRSA. Enterococci, which have some a part of the normal faecal flora of humans and animals have generally emerged as important nosocomial pathogens. Acquired resistance to vancomycin and teicoplanin in...

OBJECTIVE To evaluate the susceptibility pattern of S. aureus and enterococci to teicoplanin using an in vitro method. METHODS Between February and November 2011, valid bacteriological samples were collected at three hospitals in three cities in Pakistan and the organism was isolated. Only samples containing S. aureus or enterococci were tested for their sensitivity to teicoplanin and various...

The future of the CDS Registrants as CDS users continue to grow and number over 200 at present. The CDS method is now being used by laboratories in South East Asia, India and South Africa. It is unfortunate that a number of Australian public laboratories have changed from using the CDSmethod to othermethods as a result of executive decisions apparently based on reasons other than scientific mer...

Enterococci have become increasingly important nosocomial pathogens in many hospitals in the United States within the past few years. This is a result of an increased incidence of enterococci resistance to many antimicrobials. Drugs that were once the mainstay in the treatment of enterococci, including penicillins, aminoglycosides, and vancomycin, are no longer effective in many situations wher...

To the Editor: Vancomycin-resistant Enterococcus (VRE) has become an important nosocomial pathogen because of its rapid spread, limited therapy options, mortality, and the possibility of transfer of vancomycin resistance to other pathogens such as Staphylococcus aureus. Vancomycin-resistant E. faecium (VREF) and E. faecalis were fi rst described in 1988 (1,2).They have become major noso-comial ...

Vancomycin and ampicillin resistance in clinical Enterococcus faecium strains has developed in the past decade. Failure to adhere to strict infection control to prevent the spread of these pathogens has been well established. New data implicate the use of specific classes of antimicrobial agents in the spread of vancomycin-resistant enterococci (VRE). Extended-spectrum cephalosporins and drugs ...